WIC
BIIB icon

Woodmont Investment Counsel’s Biogen BIIB Stock Holding History

Woodmont Investment Counsel’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-150
Closed -$47K – 237
2016
Q3 		$47K Buy
+150
New +$44.4K 0.01% 272
2016
Q2 		– Sell
-150
Closed -$39K – 213
2016
Q1 		$39K Hold
150
– – 0.01% 282
2015
Q4 		$46K Hold
150
– – 0.01% 273
2015
Q3 		$44K Hold
150
– – 0.01% 274
2015
Q2 		$61K Buy
+150
New +$60.2K 0.02% 243

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Woodmont Investment Counsel's BIIB Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Biogen (BIIB) in Q4 2016, closing a stake of 150 shares — an estimated $47K sold.

Woodmont Investment Counsel first reported a position in BIIB in Q2 2015 and held it in 5 quarters. The position peaked at $61K in Q2 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 150 Biogen shares in Q4 2016, an estimated $47K.
  • Woodmont Investment Counsel first reported a position in Biogen in Q2 2015 and held it in 5 quarters.
  • Woodmont Investment Counsel's Biogen position peaked at $61K in Q2 2015.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.